🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. MBG453

    Novartis Pharmaceuticals

    Myelodysplastic Syndromes

    phase 1 small molecule terminated

    1 trial

  2. MGL-3196

    Madrigal Pharmaceuticals EU Limited

    Healthy

    phase 1 small molecule completed

    3 trials

  3. MGL-3196

    Madrigal Pharmaceuticals EU Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  4. MGL-3196 Tablet

    Madrigal Pharmaceuticals EU Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  5. MKC-1

    CASI Pharmaceuticals

    Hematological Malignancies

    phase 1 small molecule completed

    1 trial

  6. MMV390048 40 mg

    CNS Pharmaceuticals

    Malaria

    phase 1 small molecule completed

    1 trial

  7. MP-424 (Telaprevir)

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  8. MP-424(H), PEG-IFN-a-2b, RBV

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  9. MT203 80 mg or matching Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. MTX110

    Biodexa Pharmaceuticals Plc

    Recurrent Glioblastoma

    phase 1 small molecule terminated

    1 trial

  11. MarzAA (marzeptacog alfa [activated])

    CATALYST PHARMACEUTICALS, INC.

    Hemophilia A

    phase 1 mab completed

    1 trial

  12. Mavorixafor

    X4 Pharmaceuticals, Inc

    Waldenstrom's Macroglobulinemia

    phase 1 small molecule completed

    1 trial

  13. Mavorixafor

    X4 Pharmaceuticals, Inc

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  14. Mavorixafor

    X4 Pharmaceuticals, Inc

    Hepatic Insufficiency

    phase 1 small molecule active

    1 trial

  15. Metronidazole + MMX Mesalazine/mesalamine placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  16. Microgestin®

    IRONWOOD PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. Midazolam

    ENANTA PHARMACEUTICALS INC

    NASH

    phase 1 small molecule completed

    1 trial

  18. Midazolam Syrup

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  19. Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives

    Hoffmann-La Roche

    Healthy Overweight or Obese

    phase 1 other active

    1 trial

  20. N-Acetylcysteine

    United Therapeutics Europe Ltd

    Mitochondrial Disease

    phase 1 small molecule active

    1 trial

  21. N-acetyl cysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  22. N-acetylcysteine

    Ultragenyx UK Limited

    Parkinson's Disease

    phase 1 small molecule completed

    1 trial

  23. N-acetylcysteine, NAC, and calcitriol

    United Therapeutics Europe Ltd

    HIE - Perinatal Hypoxic - Ischemic Encephalopathy

    phase 1 small molecule completed

    1 trial

  24. NCO-48 Fumarate

    LIGAND PHARMACEUTICALS INC

    Hepatitis B

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources